RePORT ⟩ RePORTER

Skip Navigation Links

Search Results

Project Details

NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents

Project Number75N91019D00024-P00006-759101900135-1

Contact PI/Project LeaderCASE, CHRISTOPHER

Awardee OrganizationLEIDOS BIOMEDICAL RESEARCH, INC.

Description

Abstract Text

The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. The NIAID mission and scope includes rapidly responding to infectious disease outbreaks through research, development and clinical testing of therapeutics and vaccines against diseases caused by pathogens that threaten public health such as, HIV, pandemic influenza, and emerging and re-emerging infectious diseases like Ebola, Zika, and Malaria.

Public Health Relevance Statement

Data not available.

NIH Spending Category

BiotechnologyClinical ResearchEmerging Infectious DiseasesHIV/AIDSImmunizationInfectious DiseasesOrphan DrugPreventionRare DiseasesVaccine RelatedVaccine Related (AIDS)Vector-Borne Diseases

Project Terms

AntibodiesCommunicable DiseasesDataDiseaseDisease OutbreaksEbolaEmerging Communicable DiseasesEvaluationFutureHIVHealthHumanInvestigational New Drug ApplicationMalariaMissionMonoclonal AntibodiesNational Institute of Allergy and Infectious DiseasePublic HealthVaccinesZIKAhuman diseaseimprovedpandemic influenzapathogenpre-clinical assessmentpreclinical safetyresearch and developmentresearch clinical testingtherapeutic evaluation

Details

Contact PI/ Project Leader

Name

CASE, CHRISTOPHER

Title

Contact

Other PIs

Not Applicable

Program Official

Name

Contact

Email not available

Organization

Name

LEIDOS BIOMEDICAL RESEARCH, INC.

City

FREDERICK

Country

UNITED STATES (US)

Department Type

Unavailable

Organization Type

Domestic For-Profits

State Code

Congressional District

Other Information

Opportunity Number

Study Section

Fiscal Year

2022

Award Notice Date

Administering Institutes or Centers

National Institute of Allergy and Infectious Diseases

CFDA Code

DUNS Number

159990456

UEI

HV8BH9BPG8Y9

Project Start Date

30-September-2019

Project End Date

11-September-2027

Budget Start Date

Budget End Date

Project Funding Information for 2022

Total Funding

$2,198,288

Direct Costs

Indirect Costs

Year	Funding IC	FY Total Cost by IC
2022	National Institute of Allergy and Infectious Diseases	$2,198,288

NIH Categorical SpendingClick here for more information on NIH Categorical Spending

Funding IC	FY Total Cost by IC	NIH Spending Category
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES	$1,648,716	Vaccine Related (AIDS)
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES	$2,198,288	Biotechnology; Clinical Research; Emerging Infectious Diseases; HIV/AIDS; Immunization; Infectious Diseases; Orphan Drug; Prevention; Rare Diseases; Vaccine Related; Vector-Borne Diseases

Sub Projects

No Sub Projects information available for 75N91019D00024-P00006-759101900135-1

Publications

Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.

No Publications available for 75N91019D00024-P00006-759101900135-1

Patents

No Patents information available for 75N91019D00024-P00006-759101900135-1

Outcomes

The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.

No Outcomes available for 75N91019D00024-P00006-759101900135-1

Clinical Studies

No Clinical Studies information available for 75N91019D00024-P00006-759101900135-1

News and More

Section Menu